ERBB2 and breast cancer: Risk factors of developing BM in breast cancer patients included younger age, coexisting pulmonary or liver metastasis, hormone receptor negativity, HER2 positivity, more metastatic lesions, and larger BM lesion size (Aoyama, 2011).